MAL2 inhibitors are a class of chemical compounds that target the protein MAL2, short for Myelin and Lymphocyte Protein 2. MAL2 is a transmembrane protein primarily found in various cell types, including epithelial cells and certain immune cells. It is involved in the regulation of membrane trafficking and plays a crucial role in maintaining the integrity and functionality of cellular membranes. MAL2 is particularly important in the formation and maintenance of apical and basolateral membrane domains in epithelial cells, which are essential for proper cellular function and tissue organization.
Inhibitors of MAL2 typically work by interfering with its function or expression, disrupting the normal processes of membrane trafficking and organization. This disruption can have various cellular consequences, depending on the specific mechanism of the inhibitor. Some MAL2 inhibitors may directly bind to the MAL2 protein, preventing its interactions with other cellular components, while others may modulate signaling pathways that regulate MAL2 expression or activity. By targeting MAL2, these inhibitors have the potential to impact cellular processes such as membrane protein sorting, vesicle transport, and cell polarization. Further research into the precise mechanisms and potential applications of MAL2 inhibitors is ongoing, as scientists seek to better understand their implications in various cellular contexts.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, a kinase involved in many signaling pathways, potentially affecting MAL2-related processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor, it may indirectly influence MAL2 activity by altering downstream signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor, similar to U0126, could affect MAL2 activity indirectly through the MAPK pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, a key regulator in cell growth and proliferation, possibly affecting MAL2's role. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, potentially altering signaling pathways associated with MAL2. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
P38 MAPK inhibitor, could modify cellular processes related to MAL2. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor, may indirectly influence MAL2 by affecting protein degradation pathways. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Another proteasome inhibitor, potentially affecting MAL2's cellular environment. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Src family kinase inhibitor, might alter signaling pathways interacting with MAL2. | ||||||
Imatinib mesylate | 220127-57-1 | sc-202180 sc-202180A | 25 mg 100 mg | $44.00 $109.00 | 61 | |
Inhibits BCR-ABL and c-Kit, could indirectly impact MAL2 through these pathways. | ||||||